Myelodysplastic SyndromesBone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousAnemia, Refractory, with Excess of BlastsAnemia, RefractoryAnemia, AplasticLeukemia, Myeloid, AcuteWhole-Body IrradiationLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningBone and BonesSyndromeLeukemia, MyeloidBusulfanHematopoietic Stem CellsBone Marrow DiseasesLiver TransplantationTransplantation ChimeraTissue DonorsLeukemia, Myelomonocytic, ChronicGraft SurvivalTreatment OutcomeCyclophosphamideHistocompatibility TestingBone Marrow PurgingHematopoiesisHistocompatibilityAcute DiseaseMedical OncologyBone Marrow ExaminationRemission InductionRecurrenceCombined Modality TherapyPancytopeniaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsTransplantation, IsogeneicSurvival AnalysisKidney TransplantationImmunosuppressive AgentsPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsChromosomes, Human, Pair 5Mice, Inbred C57BLRetrospective StudiesHematologic DiseasesRadiation ChimeraAntineoplastic Combined Chemotherapy ProtocolsKaryotypingSurvival RateBone Marrow NeoplasmsLymphoma, Non-HodgkinCytarabineStem Cell TransplantationMyeloproliferative DisordersAnemia, SideroblasticAzacitidineGraft RejectionColony-Forming Units AssayChromosome AberrationsHepatic Veno-Occlusive DiseaseImmunosuppressionBone RemodelingGranulocyte Colony-Stimulating FactorTransplantation ImmunologyDisease-Free SurvivalAntigens, CD34Graft vs Host ReactionFollow-Up StudiesPreleukemiaHLA AntigensT-LymphocytesLymphocyte DepletionFlow CytometryLeukocyte TransfusionHeart TransplantationCyclosporineThalidomideLeukocyte CountFatal OutcomeSevere Combined ImmunodeficiencyMonosomyChimeraCell DifferentiationBlood TransfusionAntilymphocyte SerumImmunophenotypingOncology NursingLung TransplantationBlood Cell CountNeoplasms, Second PrimaryActuarial AnalysisCytogeneticsGranulocytes